269 related articles for article (PubMed ID: 32434942)
1. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
[No Abstract] [Full Text] [Related]
2. Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Lewis LA; Moustafa IY; Saha S; Zheng B; Nowak N; Rice PA; Varki A; Ram S
J Infect Dis; 2020 Oct; 222(10):1641-1650. PubMed ID: 32692363
[TBL] [Abstract][Full Text] [Related]
3. Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
Gulati S; Schoenhofen IC; Whitfield DM; Cox AD; Li J; St Michael F; Vinogradov EV; Stupak J; Zheng B; Ohnishi M; Unemo M; Lewis LA; Taylor RE; Landig CS; Diaz S; Reed GW; Varki A; Rice PA; Ram S
PLoS Pathog; 2015 Dec; 11(12):e1005290. PubMed ID: 26630657
[TBL] [Abstract][Full Text] [Related]
4. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
5. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
[TBL] [Abstract][Full Text] [Related]
6.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
7. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
8. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of Legionaminic Acid and Its Incorporation Into Glycoconjugates.
Schoenhofen IC; Young NM; Gilbert M
Methods Enzymol; 2017; 597():187-207. PubMed ID: 28935102
[TBL] [Abstract][Full Text] [Related]
11. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
[TBL] [Abstract][Full Text] [Related]
12. An optimized Factor H-Fc fusion protein against multidrug-resistant
Shaughnessy J; Chabeda A; Tran Y; Zheng B; Nowak N; Steffens C; DeOliveira RB; Gulati S; Lewis LA; Maclean J; Moss JA; Wycoff KL; Ram S
Front Immunol; 2022; 13():975676. PubMed ID: 36110842
[TBL] [Abstract][Full Text] [Related]
13. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.
Rest RF; Frangipane JV
Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573
[TBL] [Abstract][Full Text] [Related]
14. Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
Ram S; Shaughnessy J; DeOliveira RB; Lewis LA; Gulati S; Rice PA
Immunobiology; 2016 Oct; 221(10):1110-23. PubMed ID: 27297292
[TBL] [Abstract][Full Text] [Related]
15. L. pneumophila CMP-5,7-di-N-acetyllegionaminic acid synthetase (LpCLS)-involved chemoenzymatic synthesis of sialosides and analogues.
McArthur JB; Santra A; Li W; Kooner AS; Liu Z; Yu H; Chen X
Org Biomol Chem; 2020 Jan; 18(4):738-744. PubMed ID: 31912849
[TBL] [Abstract][Full Text] [Related]
16. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H
Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853
[TBL] [Abstract][Full Text] [Related]
17. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.
Wetzler LM; Barry K; Blake MS; Gotschlich EC
Infect Immun; 1992 Jan; 60(1):39-43. PubMed ID: 1729195
[TBL] [Abstract][Full Text] [Related]
18. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens.
de la Paz H; Cooke SJ; Heckels JE
Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():913-20. PubMed ID: 7539687
[TBL] [Abstract][Full Text] [Related]
19. Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
Ram S; Shaughnessy J; de Oliveira RB; Lewis LA; Gulati S; Rice PA
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28460033
[TBL] [Abstract][Full Text] [Related]
20. Interaction of pathogenic Neisseria with host defenses. What happens in vivo?
Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D
Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
